CAMBRIDGE, Mass., Feb. 12, 2008 (PRIME NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today announced that Jeffrey K. Tong, Ph.D., Vice President, Corporate and Product Development, will be presenting a company overview at the 20th Annual Roth OC Growth Stock Conference. Infinity’s presentation will take place on Tuesday, February 19, 2008 at 8:00 a.m. PST (11:00 a.m. EST).
